Loading
IVF Hartmann Holding AG Stock: price and insider trades · Switzerland
No insider purchase over the last 90 days. The latest was filed 13 Mar 2026.
IVF Hartmann Holding AG: what insiders have been doing
Every trade that managers of IVF Hartmann Holding AG disclose to SIX SER is tracked on this page. The company sits in the Health Care sector and is based in Neuhausen am Rheinfall. It was founded in 1870. From 18 October 2025 to 18 October 2026, the disclosure feed for IVF Hartmann Holding AG logged 1 filing by 1 insider.
Only purchases show up on the open market, 1 purchase in all worth €33k, filed by 1 insider. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. One trade stands out by size: a purchase of €33k, disclosed on 13 March 2026, or 0.0097% of market capitalisation. Among those who bought: 1 senior executive.
The most recent open-market purchase was published on 13 March 2026, 219 days ago.
Compared with its exchange (178 companies, median 9 filings), a count of 1 filing is below the norm. The full history, which starts in 2023, counts 3 purchases against no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Anixa Biosciences Inc. Source: insider filings from SIX SER. Past trades are no guide to future returns.
Key facts
Headquarters: Neuhausen am Rheinfall · Founded: 1870
Source: Wikidata (CC0).
Insider Decl.
3
Thresholds
n/a
Buy Volume
€56,448
3 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleAnonymous (Executive member of the board of directors / member of senior management)1 buy
Since the insiders bought
- Anonymous (Executive member of the board of directors / member of senior management)-14.1%Entry CHF 145.00 · Close at T+90 CHF 124.50
- Anonymous (Non-executive member of the board of directors)+24.8%Entry CHF 109.00 · Close at T+365 CHF 136.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 3,174 of 24,148 companies
71.3
score / 100
Value63
Quality79
FCF yld5.9%
Earn yld6.1%
EV/EBITDA11.4x
ROE13%
Gross mgn56%
Net mgn11%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CHF 125.00
Analyst consensus
Income statement
RevenueCHF 161.7M
Gross profitCHF 89.8M56% margin
EBITDACHF 26.2M16% margin
Net incomeCHF 18.3M11.9% margin
Valuation
PER (trailing)14.8x
P/Book1.9x
Beta0.21
Balance sheet & cash
Market capCHF 297.7M
Total debtCHF 1.4M
Free Cash FlowCHF 17.5M
Debt / Equity0%
Profitability & ownership
ROE13.5%
ROA7.8%
% insiders76.8%
% institutions1.6%
Last declaration on 13 March 2026
Declarations3 total
▲
Anonymous (Executive member of the board of directors / member of senior management)
206 shares@ CHF 145.000.0097% mcap100.0% of flowISIN CH0187624256SIX:T1Q3D00047
Canonical exit: 11 Jun 2026 (T+90)
100 shares@ CHF 112.000.0034% mcap50.1% of flowISIN CH0187624256SIX:T1N8N00022
Canonical exit: 21 Nov 2023 (T+90)
100 shares@ CHF 112.000.0034% mcap49.9% of flowISIN CH0187624256SIX:T1N8L000A3
Canonical exit: 19 Nov 2023 (T+90)
3 of 3 declarations
About IVF Hartmann Holding AG
IVF Hartmann Holding AG is a company operating in the health and pharmaceutical sector. It is listed on the Swiss stock exchange XSWX.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
